Work

A Novel Anti-CD22 Camelid Immunotoxin Fused to Diphtheria Toxin for Targeted B-Cell Malignancy Therapy

Year: 2026

Type: article

Source: Current Pharmaceutical Design

DOI: 10.2174/0113816128432068260209055133

Authors: Alireze Erfani, Fatemeh Kazemi-Lomedasht, Vahab Ziaei, Sheyda Mohammadkhani, Leila Ghazizadeh, Saeid Mohammadi Motamed, Mahdi Habibi-Anbouhi

Institutions: Islamic Azad University, Tehran, Pasteur Institute of Iran

Language: English

Topic: Toxin Mechanisms and Immunotoxins

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7141812755

FWCI:

Cites:

Cited by:

Related to: